Neoadjuvant Pertuzumab and Trastuzumab concurrent or sequential with an Anthracycline-containing or concurrent with an Anthracycline-free standard regimen: a randomized phase II Study (TRYPHAENA) (Abstract S5-6; Schneeweiss A et al.)